Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cazzaniga

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Leukemia|February 13, 2009
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocolV H J Van der Velden, L Corral, M G Valsecchi, et al.
Leukemia|November 15, 2011
Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemiaE Ellinghaus, M Stanulla, G Richter, et al.
Lancet (London, England)|December 16, 1998
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodJ J van Dongen, T Seriu, E R Panzer-Grümayer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocolJ Stutterheim, P de Lorenzo, I M van der Sluis, et al.
Leukemia|May 4, 2007
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurementsJ Saldanha, M Silvy, N Beaufils, et al.
Leukemia|October 30, 2013
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcomeC J Harrison, A V Moorman, C Schwab, et al.
Leukemia|July 24, 2015
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative studyJ M Boer, A van der Veer, D Rizopoulos, et al.
Leukemia|March 13, 2019
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|January 16, 2020
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|April 5, 2023
The KMT2A recombinome of acute leukemias in 2023C Meyer, P Larghero, B Almeida Lopes, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Leukemia|February 13, 2009
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocolV H J Van der Velden, L Corral, M G Valsecchi, et al.
Leukemia|November 15, 2011
Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemiaE Ellinghaus, M Stanulla, G Richter, et al.
Lancet (London, England)|December 16, 1998
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodJ J van Dongen, T Seriu, E R Panzer-Grümayer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocolJ Stutterheim, P de Lorenzo, I M van der Sluis, et al.
Leukemia|May 4, 2007
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurementsJ Saldanha, M Silvy, N Beaufils, et al.
Leukemia|October 30, 2013
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcomeC J Harrison, A V Moorman, C Schwab, et al.
Leukemia|July 24, 2015
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative studyJ M Boer, A van der Veer, D Rizopoulos, et al.
Leukemia|March 13, 2019
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|January 16, 2020
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|April 5, 2023
The KMT2A recombinome of acute leukemias in 2023C Meyer, P Larghero, B Almeida Lopes, et al.
Pageof 7